Profound Inhibition of Antigen-Specific T-Cell Effector Functions by Dasatinib

Abstract

These findings indicate that caution is warranted with use of this drug in the clinical setting and provide a rationale to explore the potential of dasatinib as an immunosuppressant in the fields of transplantation and T-cell-driven autoimmune diseases.